A

Acumen Pharmaceuticals
D

ABOS

3.14000
USD
-0.18
(-5.42%)
مغلق
حجم التداول
3,755
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
190,200,555
المقالات

العنوان: Acumen Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers.